产品详情
靶点信息
B-Raf (V600E) (Cell-free assay) | B-Raf (Cell-free assay) | C-Raf (Cell-free assay) | ||
0.8 nM | 3.2 nM | 5.0 nM |
In vitro (25°C) | DMSO | 28 mg/mL (53.89 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 2% DMSO+45% PEG 300+2% Tween 80+ddH2O | 4 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 19.25 mL | 96.23 mL | 192.46 mL |
0.5 mM | 3.85 mL | 19.25 mL | 38.49 mL |
1 mM | 1.92 mL | 9.62 mL | 19.25 mL |
5 mM | 0.38 mL | 1.92 mL | 3.85 mL |
*The above data is based on the productmolecular weight 519.6 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A11381 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 519.6 |
Formula | C23H20F3N5O2S2 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 1195765-45-7 |
Synonyms | GSK2118436A |
SMILES | CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F |
产品资料
产品标签
Product Questions
Product Questions
LGX 818 (Encorafenib)
LGX 818 (Encorafenib)是一种Raf激酶抑制剂,具有潜在的抗肿瘤活性。
B-Raf-inhibitor 1
B-Raf inhibitor 1是有效的选择性B-Raf抑制剂,对A375增殖和A375 p-ERK的细胞IC50分别为0.31 uM和2 nM。
PF-04880594
PF-04880594是RAF抑制剂,BRAF/BRAFV599E和c-RAF的IC50值分别为0.19 nM/0.13 nM和0.39 nM。
RAF265 (CHIR-265)
RAF265 (CHIR-265)是一种口服,高度选择性的RAF和VEGFR激酶抑制剂,可控制或正常化VEGFR-2,同时抑制B-raf和c-Raf…
RO5126766 (CH5126766)
RO5126766 (CH5126766)是对Raf和MEK丝裂原激活的蛋白激酶(MAPK)具有特异性的蛋白激酶抑制剂,具有潜在的抗肿…